Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
mi
from
Kelowna,
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Kelowna,
Click here to add this to my saved trials
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated:  1/13/2016
mi
from
Los Angeles, CA
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated: 1/13/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated:  1/13/2016
mi
from
Los Angeles, CA
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated: 1/13/2016
West Los Angeles VA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated:  1/13/2016
mi
from
Ann Arbor, MI
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
Status: Enrolling
Updated: 1/13/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Functional Magnetic Stimulation Enhances Gastrointestinal Motility in Patients With Chronic Constipation
A Prospective Trial to Study Whether Functional Magnetic Stimulation Enhances Gastrointestinal Motility in Patients With Chronic Constipation
Status: Enrolling
Updated:  2/2/2016
mi
from
Cleveland, OH
Functional Magnetic Stimulation Enhances Gastrointestinal Motility in Patients With Chronic Constipation
A Prospective Trial to Study Whether Functional Magnetic Stimulation Enhances Gastrointestinal Motility in Patients With Chronic Constipation
Status: Enrolling
Updated: 2/2/2016
Cleveland Clinic Digestive Disease Institute
mi
from
Cleveland, OH
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Huntsville, AL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Huntsville, AL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Chandler, AZ
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Chandler, AZ
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Phoenix, AZ
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Tucson, AZ
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
North Little Rock, AR
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
North Little Rock, AR
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Anaheim, CA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Chula Vista, CA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Garden Grove, CA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
La Mesa, CA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
La Mesa, CA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Newport Beach, CA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
North Hollywood, CA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
North Hollywood, CA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Orange, CA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
San Diego, CA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Thousand Oaks, CA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Colorado Springs, CO
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Bristol, CT
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Bristol, CT
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Boynton Beach, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Coral Gables, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
DeLand, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
DeLand, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Hialeah, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Hialeah, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Inverness, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Inverness, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Jupiter, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Jupiter, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Kissimmee, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Lauderdale Lakes, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Miami, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Miami, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Miami, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Miami, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Miami, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Miami, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Orlando, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Ormond Beach, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
South Miami, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
South Miami, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Tampa, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
West Palm Beach, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Winter Park, FL
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Winter Park, FL
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Atlanta, GA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Oakwood, GA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Oakwood, GA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Sandy Springs, GA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Evansville, IN
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Evansville, IN
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Bastrop, LA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Bastrop, LA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Metairie, LA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Metairie, LA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Shreveport, LA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Shreveport, LA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Baltimore, MD
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Chevy Chase, MD
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Chevy Chase, MD
Click here to add this to my saved trials